Literature DB >> 14527262

AHCPR and the changing politics of health services research.

Bradford H Gray1, Michael K Gusmano, Sara R Collins.   

Abstract

The Agency for Health Care Policy and Research has had a turbulent history. Created with little opposition in 1989, it narrowly escaped being eliminated in 1995, only to be reauthorized (with a new mandate and name--the Agency for Healthcare Research and Quality, or AHRQ) with overwhelming support in 1999. In focusing on budgetary history, this paper sheds light on why health services research (HSR) has difficulty obtaining funding from a government that is willing to spend vast sums on basic biomedical research. The paper argues that three strategies--bureaucratic, marketing, and constituency building--that advocates adopted in the late 1980s made HSR more visible and consequential and were responsible for AHCPR's budgetary successes as well as its near-demise.

Mesh:

Year:  2003        PMID: 14527262     DOI: 10.1377/hlthaff.w3.283

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  15 in total

Review 1.  Policy-relevant research: when does it matter?

Authors:  Gary M Franklin; Thomas M Wickizer; Deborah Fulton-Kehoe; Judith A Turner
Journal:  NeuroRx       Date:  2004-07

2.  Health services research as a source of legislative analysis and input: the role of the California Health Benefits Review Program.

Authors:  Thomas R Oliver; Rachel Friedman Singer
Journal:  Health Serv Res       Date:  2006-06       Impact factor: 3.402

3.  The emergence of clinical practice guidelines.

Authors:  George Weisz; Alberto Cambrosio; Peter Keating; Loes Knaapen; Thomas Schlich; Virginie J Tournay
Journal:  Milbank Q       Date:  2007-12       Impact factor: 4.911

Review 4.  Pathways to the use of health services research in policy.

Authors:  Marsha Gold
Journal:  Health Serv Res       Date:  2009-03-16       Impact factor: 3.402

5.  Swimming upstream: comparative effectiveness research in the US.

Authors:  Jeremy A Greene
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Improving the quality of medical care: the normativity of evidence-based performance standards.

Authors:  Sandra J Tanenbaum
Journal:  Theor Med Bioeth       Date:  2012-08

7.  "Can we declare victory and move on?" The case against funding burden-of-disease studies.

Authors:  Steven Kymes
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

8.  Provincial elections and timing of cancer drug funding.

Authors:  A Srikanthan; S S Gill; K K W Chan
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

9.  Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade.

Authors:  Mark D Neuman; Charles L Bosk; Lee A Fleisher
Journal:  BMJ Qual Saf       Date:  2014-08-18       Impact factor: 7.035

Review 10.  The policy debate over public investment in comparative effectiveness research.

Authors:  Eugene C Rich
Journal:  J Gen Intern Med       Date:  2009-04-21       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.